COLONY GROUP LLC - RegeneRx Biopharmaceuticals ownership

RegeneRx Biopharmaceuticals's ticker is RGRX and the CUSIP is 75886X108. A total of 1 filers reported holding RegeneRx Biopharmaceuticals in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
COLONY GROUP LLC ownership history of RegeneRx Biopharmaceuticals
ValueSharesWeighting
Q1 2020$3,000
+50.0%
15,000
+50.0%
0.00%
Q2 2019$2,0000.0%10,0000.0%0.00%
Q1 2019$2,0000.0%10,0000.0%0.00%
Q4 2018$2,0000.0%10,0000.0%0.00%
Q3 2018$2,00010,0000.00%
Other shareholders
RegeneRx Biopharmaceuticals shareholders Q3 2023
NameSharesValueWeighting ↓
DUMONT & BLAKE INVESTMENT ADVISORS LLC 22,300$7,0000.00%
Williams Jones Wealth Management, LLC. 200,000$63,0000.00%
View complete list of RegeneRx Biopharmaceuticals shareholders